Customized research for DMAC vs. RGNX!

All in one page research, scroll down. Compare two other stocks.

Note: Don't forget to explore SpeculatingStocks further... from the SpeculatingStocks.com Homepage you can Discover Stocks, Post Anonymously, and React. No Login Required.

Done! Side by Side Research Below for DMAC vs. RGNX.


↗ Join Our Free Email Newsletter.




Diamedica Therapeutics Inc. vs. REGENXBIO Inc.

Industry Match! Industry of Both DMAC and RGNX:

Health Care/Life Sciences

DMAC
Data Last Updated: More than 1 mo ago

↻  Update Column 1 to Most Recent

Key Statistics

Cap: 32.785M


P/E: N/A

P/S: 65.57

Q P/B: 2.8

Y Rev: 500,000

Q Rev: -

Beta: 2.74

DMAC Share Stats

Outstanding Shares

11.96M

Float Shares

8.67M

Percent of Float Short

0.04%

DMAC Insider Stats

Percent Outstanding Insider Ownership

N/A

Percent Outstanding Institution Ownership

N/A

DMAC Social Stats

Followers

0

B/S Rating Today

0

B/S Rating All-Time

N/A

More Social Data

DMAC in Pulse Portal

Stream of Posts

DMAC Symbol Page

Share DMAC Insights

Express Sentiment

'Buy' or 'Sell' DMAC

DMAC Profile

CEO

Mr. Rick John Pauls

Exchange

Nasdaq

Employees

9.00

About

DiaMedica Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development of novel recombinant proteins. It offers DM199 product which focuses on acute ischemic stroke (AIS), and chronic kidney disease (CKD). The company was founded...

DMAC Financials

Annual Financials

Income Statement

Revenue

500,000

Net Income

(5.73M)

Cash Flow Statement

Change in Cash / Investments

15.47M

Balance Sheet

Cash / Investments

16.82M

Short Term Debt

None

Long Term Debt

None

Total Current Assets

17.97M

Total Current Liabilities

1.3M

Total Assets

18.34M

Total Liabilities

1.31M

Stockholder Equity

17.03M

Quarterly Financials

Income Statement

Q Revenue

-

Q Net Income

(2.47M)

Cash Flow Statement

Q Change in Cash / Investments

258,896

Balance Sheet

Q Cash / Investments

10.97M

Q Short Term Debt

50,000

Q Long Term Debt

None

Q Total Current Assets

12.28M

Q Total Current Liabilities

947,000

Q Total Assets

12.8M

Q Total Liabilities

1.1M

Q Stockholder Equity

11.7M

DMAC Charts

10-Year Chart

DMAC 10-Year Chart

5-Year Chart

DMAC 5-Year Chart

1-Year Chart

DMAC 1-Year Chart

6-Month Chart

DMAC 6-Month Chart

3-Month Chart

DMAC 3-Month Chart

1-Month Chart

DMAC 1-Month Chart

1-Day Chart

DMAC 1-Day Chart

RGNX
Data Last Updated: More than 2 wks ago

↻  Update Column 2 to Most Recent

Key Statistics

Cap: 1.408B


P/E: N/A

P/S: 6.44

Q P/B: 3.01

Y Rev: 218.51M

Q Rev: 14.7M

Beta: 0.79

RGNX Share Stats

Outstanding Shares

36.64M

Float Shares

33.31M

Percent of Float Short

13.78%

RGNX Insider Stats

Percent Outstanding Insider Ownership

N/A

Percent Outstanding Institution Ownership

N/A

RGNX Social Stats

Followers

1

B/S Rating Today

0

B/S Rating All-Time

N/A

More Social Data

RGNX in Pulse Portal

Stream of Posts

RGNX Symbol Page

Share RGNX Insights

Express Sentiment

'Buy' or 'Sell' RGNX

RGNX Profile

CEO

Mr. Donald J. Hayden

Exchange

Nasdaq

Employees

192.00

About

REGENXBIO, Inc. is a biotechnology company, which engages in the development, commercialization, and licensing of recombinant adeno-associated virus gene therapy. The company was founded by Kennth T. Mills and James M. Wilson on July 16, 2008 and is headquartered in...

RGNX Financials

Annual Financials

Income Statement

Revenue

218.51M

Net Income

99.94M

Cash Flow Statement

Change in Cash / Investments

29.73M

Balance Sheet

Cash / Investments

319.76M

Short Term Debt

None

Long Term Debt

None

Total Current Assets

337.91M

Total Current Liabilities

22.18M

Total Assets

543.81M

Total Liabilities

34.97M

Stockholder Equity

508.85M

Quarterly Financials

Income Statement

Q Revenue

14.7M

Q Net Income

(34.58M)

Cash Flow Statement

Q Change in Cash / Investments

24.45M

Balance Sheet

Q Cash / Investments

331.72M

Q Short Term Debt

2.51M

Q Long Term Debt

None

Q Total Current Assets

360.23M

Q Total Current Liabilities

31.35M

Q Total Assets

509.24M

Q Total Liabilities

40.84M

Q Stockholder Equity

468.4M

RGNX Charts

10-Year Chart

RGNX 10-Year Chart

5-Year Chart

RGNX 5-Year Chart

1-Year Chart

RGNX 1-Year Chart

6-Month Chart

RGNX 6-Month Chart

3-Month Chart

RGNX 3-Month Chart

1-Month Chart

RGNX 1-Month Chart

1-Day Chart

RGNX 1-Day Chart

 

 


Research

×
Stock Streams
Global Streams

UserStreamReactionsPulseStreamSpecStreamEchoStream
Stock Streams

Message BoardSpecStream TrendingTrending StocksTV Buzz

IPO Buzz (Pricings)IPO Buzz (Upcoming)Stocks Gapping HigherTrending Public Companies (Top Volume Generators)

Uplisted StocksNew 52-Week Highs (NASDAQ)New 52-Week Highs (NYSE)New 52-Week Highs (AMEX)

Technical IndicatorsUpgradesDowngradesRecent Earnings Surprises

Market Streams

Trending IndustriesETF's by SectorSectors Top to BottomCommodities

Economic IndicatorsStock ExchangesETF Movers
Premarket Streams

NASDAQ Premarket GainersNASDAQ Premarket LosersOverseas MarketsS&P Premarket Gainers & Losers

Morning Earning ReleasesFutures

After Hours Streams

After Hours GainersAfter Hours DeclinersAfter Hours Most ActiveAfter the Bell Earning Releases
Symbol Alert Streams

Market Cap MilestonesAbove Average VolumeCurrent Movers - GainersCurrent Movers - Decliners

Short Squeeze AlertsPrice to Earnings PE AlertsPrice to Sales PS AlertsPrice to Book PB Alerts

Insider Holding AlertsInstitutional Holding AlertsLow Float StocksProfitable or Not

Cash Flow PositiveHigh Beta Volatile Stocks

Media Streams

HeadlinesMedia BuzzEconomic NewsTop Stories
Social Streams

Pulse User 'Buys'Pulse User 'Sells'B/S Today Positive Sentiment MilestonesB/S Today Negative Sentiment Milestones

Stock Follower MilestonesStocks Followed by Users


Streams
Streams
            anon
   anon